Difference between revisions of "Team:Amsterdam/Design"

Line 25: Line 25:
 
                               <h3>Background</h3>
 
                               <h3>Background</h3>
 
                              
 
                              
                             <p>The driving force of our consortium's romance is the phototrophic carbon-sharing module: an engineered <i>Synechocystis</i> that fixes CO2 and produces compounds that can be used by a chemotroph to create desired end-products like biofuels.
+
                             <p>The ultimate test for any romance is lovers living together. Will they cooperate in mutually beneficial ways? Can true microbial romance be sustained? Or will our microbial relationships last no longer than a one night stand? And, in the case of (photo)synthetic consortia designed to benefit mankind by delivering products: can it be used to convert CO2 into a valuable compounds?
 +
 
 
</p>
 
</p>
 
                               <h3>Aim</h3>
 
                               <h3>Aim</h3>
 
                              
 
                              
                             <p>Productive relationships need to stand the test of time. Having experienced the perils of instability firsthand, we sought to engineer carbon production in way that would last.
+
                             <p>We developed extensive theory about consortia by an interplay of in vivo and in silico approaches shaping each others design. However, all the experimental information we've gathered to help quantitatively understand the consortia was done by cultivating the partners in isolation, trying to mimic the environment they would meet in the co-culture as much as possible. Here, we aim to validate our assumptions and efforts thus far: we want to put the members of our rationally-designed consortium - the carbon-sharing Synechocystis strain and a product-producing E. coli - together in the same compartment to test growth and product formation.
              <h3>Approach</h3>
+
             
                           
+
                            <p> Using genetic engineering strategies guided by modelling results, we used a combination of gene knock-outs and over-expressions to target a pathway that would result in growth-coupled acetate production.
+
</p>
+
 
 
 
                             </section>                   
 
                             </section>                   
Line 41: Line 39:
 
                         <div class="4u">
 
                         <div class="4u">
 
                         <section>
 
                         <section>
 +
 +
<h3>Approach</h3>
 +
                           
 +
                            <p> To assess the development of our consortia and determine final organism ratios, we innoculated 48-well plates with acetate and lactate-producing Synechocystis strains and E. coli. To test product formation, we constructed two consortia: one in which we transformed an E. coli with Bielefeld’s iso-butanol biobrick for the of CO2 to acetate to isobutanol; and another consortium based on an acetoin producing E. coli and Synechocystis engineered to produce glycerol and meso-butanediol from acetoin, showcasing the benefits of compartmentalization in consortia. Both product-producing consortia were tested in batch and turbidostat experiments.
 +
</p>
 
                
 
                
 
                               <h3>Results</h3>
 
                               <h3>Results</h3>
                           
+
                             <p>
                             <ul style = "font-family: 'Montserrat', sans-serif">
+
                          We show growth and organism ratio convergence. And, on the very last day of our project, we finally showed meso-butanodiol production in our consortium! This demonstrates how consortia can be used to implement complex redox production pathways that would be infeasible in a single organism.
<li>We engineered growth-coupled acetate production by knocking out the <i>acs</i> gene, showing that this indeed leads to stable acetate production</li>
+
 
<li>We over-expressed the Pta and AckA1 proteins to increase the flux towards acetate formation, but found that the burden this puts on growth comes at a cost.</li>
+
</ul>
+
 
.</p>
 
.</p>
  
Line 65: Line 66:
 
            
 
            
 
  <figure class ="image fit">
 
  <figure class ="image fit">
   <img src="https://static.igem.org/mediawiki/2015/6/68/Amsterdam_qp_acetate.png" alt="Acetate Qp and growth">
+
   <img src="https://static.igem.org/mediawiki/2015/9/9c/Acetate_consortia_growth.png " alt="Acetate Qp and growth">
   <figcaption>Figure 1. - Growth and Q<sub>p</sub> of strain &Delta;acs over 900 hours of continuous culture showing a constant production over the duration of the experiment.</figcaption>
+
   <figcaption>Figure 1. - Romance in action: the organisms are living happily together!/figcaption>
 
</figure>  
 
</figure>  
  
 
   
 
   
 
  <figure class ="image fit">
 
  <figure class ="image fit">
   <img src="https://static.igem.org/mediawiki/2015/3/32/Acetate_plot1.png" alt=" acetate concentrations">
+
   <img src="https://static.igem.org/mediawiki/2015/e/e1/Proof.png" alt=" acetate concentrations">
   <figcaption>Figure 2. - Acetate concentrations over time in the variety of engineered <i>Synechocystis</i> strains.</figcaption>
+
   <figcaption>Figure 2. - The eureka moment: our consortium really works!<i>Synechocystis</i> strains.</figcaption>
 
</figure>  
 
</figure>  
  
Line 83: Line 84:
 
                   </div>
 
                   </div>
 
</div>
 
</div>
</section>
+
 
+
 
+
<section id="intro" class="wrapper style5">
+
<header class = "major">
+
<h2>Change of plans</h2>
+
</header>
+
 
+
<div class="container">
+
<div class="row">
+
 
+
<div class="6u">
+
<p>
+
Different carbon compounds produced by <i>Synechocystis</i> could serve as fuel for <i>E. coli</i> in our consortium: glucose, lactate, and glycerol for example, are all products that an engineered cyanobacteria can produce.
+
</p>
+
 
+
<figure class ="image fit">
+
  <img src="https://static.igem.org/mediawiki/2015/7/76/Carbon_compounds.png" alt=" Turbidostat">
+
  <figcaption style="color: #2C3539">Figure 3. - Potential carbon compounds that <i>Synechocystis</i> can produce. </figcaption>
+
</figure>
+
+
</div>
+
<div class="6u">
+
 
+
<p>  
+
Although glucose seems like a great compound to drive sustainable bio-production with, our initial plan was to develop <i>Synechocystis</i> strains that produce all of these products, and to compare their performances in a consortium with <i>E. coli</i> generating different products. </p>
+
 
+
<p>After the initial results of lactate production came in, however, we decided to make genetic stability the central focus of our carbon fixation efforts: engineering a <i>Synechocystis</i> that produces a carbon compound in the most stable way possible such that its relationships with other consortia-species last more than one or a few nights. Based on the results of our computational tools, which parsed the genome-scale metabolic map to search for compounds that could be produced in a growth-coupled way, we decided to focus on acetate production.
+
</p>
+
</div>
+
</div>
+
</div>
+
</section>
+
 
+
 
+
  
 
<section id="Methods" class="wrapper style1">
 
<section id="Methods" class="wrapper style1">
 
<header class="major">
 
<header class="major">
<h2>Methods</h2>
+
<h2>The first step: showing growth</h2>
 
</header>
 
</header>
 
<div class="container">
 
<div class="container">
Line 128: Line 95:
 
<div class="6u">
 
<div class="6u">
 
<p>
 
<p>
As the genetic engineering of carbon production in <i>Synechocystis</i> involved relatively simple constructs, standard restriction-digestion cloning protocols were used for most engineering efforts. <i>Synechocystis</i> knock-outs were created using the specific markerless knock-out method described <a href="https://2015.igem.org/Team:Amsterdam/Project/Eng_rom/Dependecies">here</a>. This two-round knock-out approach allowed for the cultivation of knock-out strains without the need of antibiotics and thus increased flexibility of implementation in a potential consortium.
+
The first thing we wanted to demonstrate was co-culture growth in which an E. coli culture was able to grow on the carbon shared by Synechocystis. We innoculated 48-well plates with different starting ratios of Synechocystis and E. coli. We used both the lactate-producing Synechocystis strains whose genetic instability we showed earlier, as well as the acetate-producing strain based on the acs knock-out. Cells were counted using a coulter-counter before innoculation and re-counted every 24 hours for seven consecutive days. Results are shown in figure 1 for the acetate producer & E. coli consortium, while results for the lactate-producer & E. coli consortium are shown in figure 2. Overall, all consortia seem to converge to a common final ratio, showing robust population dynamics governed by the carbon-sharing dependency of E. coli on Synechocystis. This result is perfectly aligned with our in silico simulations {link} that had predicted the existence of attractor states, quite robust to fluctuations in model parameters such as the initial ratio of Synechocystis:E. coli.  
 +
 
 
</p>
 
</p>
  
<p>  
 
Acetate production involved the knock-out of the native <i>acs</i> gene and heterologous over-expression of the <i>ackA1</i> gene from <i>Lactococcus lactis</i> and <i>pta</i> gene from <i>Synechocystis</i>.</p>
 
  
<figure class ="image fit">
+
 
  <img src="https://static.igem.org/mediawiki/2015/a/a0/Acetate_pathway.png" alt=" Acetate pathway">
+
  <figcaption style="color: #2C3539">Figure 4. - Schematic overview of the targeted acetate pathway. The <i>acs</i> gene represents the recycling reaction that is knocked-out to enable growth-coupled production, while <i>ackA1</i> and <i>pta</i> were targeted to further increase acetate production. </figcaption>
+
</figure>
+
  
 
</div>
 
</div>
 
<div class="6u">
 
<div class="6u">
  
<p> The <i>acs</i> gene encodes for acetyl-CoA synthase, an enzyme that converts acetate into acetyl-CoA. This is the acetate recycling reaction in the biomass formation pathway. The reactions that actually lead to the formation of acetate as a side-product represent a two-step process and are governed by <i>pta</i>, encoding for the phosphate acetyl-transferase enzyme that converts acetyl-CoA into acetyl-phosphate, and <i>ack</i>, encoding for an acetate kinase that removes acetyl-phosphate's phosphate group to produce acetate (technically functioning as a phosphatase). Although over-expressing <i>ackA1</i> and <i>pta</i> via gene insertions is prone to the fixation of mutations, we still wanted to see its impact on overall acetate production. The following constructs were used for the knocking out of <i>acs</i> and insertion of <i>ackA1</i>, <i>pta</i>, or fused <i>ackA1/pta</i>:
 
</p>
 
 
  <figure class ="image fit">
 
  <figure class ="image fit">
   <img src="https://static.igem.org/mediawiki/2015/d/dd/Screen_Shot_2015-09-18_at_19.35.20.png" alt="acetate constructs">
+
   <img src="https://static.igem.org/mediawiki/2015/9/9c/Acetate_consortia_growth.png " alt="acetate constructs">
   <figcaption style="color: #2C3539">Figure 5. - Constructs used to knock-out <i>acs</i> and over-express </i>ackA1</i> and <i>pta</i>. All plasmids contained homologous sequences of neutral sites in the <i>Synechocystis</i> genome that enabled homologous recombination to take place in order to insert or eliminate target genes. AckA1 and Pta were expressed via the constitutive Pcpc promoter. </figcaption>
+
   <figcaption style="color: #2C3539">Figure 1. - Growth dynamics of acs + e coli consortium.</figcaption>
 
</figure>  
 
</figure>  
<p>  
+
 
After the genetic engineering steps, batch and turbidostat cultivation experiments were conducted to measure acetate production levels and stability. Acetate concentrations were measured using the Megazyme acetate assay kit.
+
<figure class ="image fit">
</p>
+
  <img src="https://static.igem.org/mediawiki/2015/5/59/Lactate_consortia_growth.png" alt="acetate constructs">
 +
  <figcaption style="color: #2C3539">Figure 2: Growth dynamics of lactate-producing Synechocystis + e. coli
 +
</figcaption>
 +
</figure>
 +
 
 
</div>
 
</div>
 
</div>
 
</div>
Line 159: Line 124:
 
<section id="Results" class="wrapper style1">
 
<section id="Results" class="wrapper style1">
 
<header class="major">
 
<header class="major">
<h2>Results</h2>
+
<h2>The next step: demonstrating production</h2>
 
</header>
 
</header>
 
<div class="container">
 
<div class="container">
Line 165: Line 130:
 
                         <div class="5u">
 
                         <div class="5u">
 
<header>
 
<header>
<h4>Stable acetate production</h4>
+
<h4>Approach 1: Acetate-production and isobutanol
 +
</h4>
 
</header>
 
</header>
<p>  By knocking out the <i>acs</i> gene, we expected to eliminate the acetate recycling reaction in the biomass formation pathway, which would lead to acetate accumulation in growth-coupled fashion. Although this is what the model indicated should happen, modelling results hardly ever translate perfectly to real-world scenarios. In order to test the <i>Synechocystis</i> <i>acs</i> mutant's acetate production (only <i>acs</i> was knocked out for this strain, <i>ack</i> and <i>pta</i> were not yet overexpressed), we conducted the turbidostat experiments described in more detail on this <a href = "https://2015.igem.org/Team:Amsterdam/Project/Phy_param/Synechocysytis">page</a>.
+
<p>  Our first attempt to demonstate product-production in a synthetic consortium involved our stable acetate-producer and an isobutanol-producing E. coli strain. The latter was obtained via the isobutanol pathway biobrick that was part of this year’s distribution kit and submitted by Bielefeld’s iGEM team last year. Their isobutanol pathway consists of four enzymes under the control of an inducible promoter. Unfortunately, despite succesfully transforming an E. coli strain, we could not demonstrate subsequent isobutanol production in neither stand-alone E. coli growing on various carbon sources nor E. coli driven by Synechocystis stable supply of acetate.
 
</p>
 
</p>
  
 
<figure class ="image fit">
 
<figure class ="image fit">
   <img src="https://static.igem.org/mediawiki/2015/6/68/Amsterdam_qp_acetate.png" alt="acetate constructs">
+
   <img src="https://static.igem.org/mediawiki/2015/a/a7/Isobutanol_consortia.png" alt="acetate constructs">
   <figcaption style="color: #2C3539">Figure 6. - Turbidostat results showing stable production of acetate by a <i>Synechocystis acs</i> mutant over long incubation periods.</figcaption>
+
   <figcaption style="color: #2C3539">Approach 3: isobutanol production</figcaption>
 
</figure>  
 
</figure>  
  
<p>
+
<h4>Approach 2: Three-step meso</i>-butanodiol production</h4>
We indeed observed stable acetate production over time, maintained well over 900 hours until the end of the experiment. The contrast this result offers to the lactate results shows that knocking out the acetate recycling reaction in the biomass-formation pathway represents a succesful strategy for inducing stable production.
+
</p>
+
<h4>Ramping up production</h4>
+
 
</header>
 
</header>
 
<p>
 
<p>
In an attempt to further increase acetate production and increase the production capacity of our consortium, we took the <i>acs</i> mutant described above and over-expressed the <i>ackA1</i> and <i>pta</i> genes - encoding the two reactions that lead to acetate formation in the central carbon metabolism pathway. During the engineering of the <i>pta</i> strain, we discovered several mutations had occurred in the Pta encoding fragment, resulting in a frame-shift mutation that removed the stop codon and extended the amino acid chain. We therefore created a second strain from scratch, but included the first strain to investigate the impact of the frameshift mutations. The three resulting strains, ackA1, pta mutated, and pta, were cultivated in a batch reactor with OD-dependent light intensity over a period of four days.  
+
In an ambitious last attempt to demonstrate product formation using a consortium, we combined an acetoin-producing E. coli strain available in our lab with a previously-engineered Synechocystis strain that produces glycerol via insertions of a gene coding for phospho-glycerol phosphatase (ggp), which catalyzes the dephosphorylation of glycerol-3-phosphate to glycerol <a href="http://www.sciencedirect.com/science/article/pii/S0168165614010517">(Savakis, 2015)</a>. We reasoned that with a modified glycerol-producing strain also created in our lab by Philipp Savakis, the separate compartments of Synechocystis and E. coli could be used to more favourably drive a reaction towards the production of meso-butanediol, an important chemical precursor for a variety of industrial chemicals and biofuels. Previous attempts involved producing meso-butanediol from acetoin within the same compartment in a single cell (figure 2). The flux to meso-butanediol, however, is hampered by the series of redox-reactions with overall unfavourable thermodynamics due to presence in the same compartment. To overcome this, we designed the following consortium:
 
</p>
 
</p>
 
 
Line 187: Line 150:
 
                 <div class="7u">
 
                 <div class="7u">
 
<br>
 
<br>
<figure class ="image fit">
+
 
   <img src="https://static.igem.org/mediawiki/2015/3/32/Acetate_plot1.png" alt="Acetate Qp and growth">
+
 
   <figcaption>Figure 7. - Total acetate concentrations over the course of tcultivation. Although acetate concentrations reach their highest values for the pta strain, the yields and Q<sub>p</sub>'s are lower than the acs mutant strain during the period of growth. Only when growth - and thus growth-coupled production - stops can pta's acetate concentrations accumulate beyond the acs mutant strain's.</figcaption>
+
<figure class ="image fit" style = "align:center">
 +
   <img src="https://static.igem.org/mediawiki/2015/9/99/Three_step_consortia.png" alt="meso-butanediol consortium">
 +
   <figcaption>Figure 4. - Consortium design for <i>meso</i>-butanediol production via glycerol and acetoin in a three-step process</figcaption>
 
</figure>  
 
</figure>  
  
<p>
+
<p>After several days of turbidostat innoculation, we managed to show <i>meso</i>-butanediol production using HPLC. Although we obtained these results mere hours before the wiki-freeze and are as such far from being fully exploited, the result demonstrates the potential of using a consortium for successfully driving product-flux using compartmentalisation in what would otherwise be an unfavourable thermodynamic environment.</p>
The results depicted in figure 7 show that although acetate concentrations were higher in the pta strain compared to the acs mutant strain (again, all engineered pta and ack strains also had the acs KO background). Nevertheless, both the total yields and Q<sub>p</sub>'s are higher for the acs mutant during the period that both strains grow. More than that, the pta strain has a lower growth rate than the acs mutant during this period, providing evidence that any non-growth coupled production strategy is ultimately out-competed during growth phases. We show that this statement holds even when the non-growth coupled strategy is implemented in a strain that already makes a product in a growth coupled fashion. The take-away here is that in order to stabilize non-growth coupled production strategies, we need synthetic gene-circuits that conditionally activate production during non-growth period. In this case, a circuit activating <i>pta</i> under dark conditions only, i.e. when <i>Synechocystis</i> does not grow, would help improve production, as at that stage, it would not produce acetate otherwise via growth-coupled production.
+
</p>
+
  
 
<figure class ="image fit" style = "align:center">
 
<figure class ="image fit" style = "align:center">
   <img src="https://static.igem.org/mediawiki/2015/e/ef/Amsterdam_table_qp_dav.png
+
   <img src="https://static.igem.org/mediawiki/2015/e/e1/Proof.png" alt="meso-butanediol consortium">
" alt="Acetate Qp and growth">
+
   <figcaption>Figure 5. - The peak that shows our consortium works!</figcaption>
   <figcaption>Table 1. - Estimated Growth and Q<sub>p</sub> for acs, ackA1, and pta <i>Synechocystis</i> strains.</figcaption>
+
 
</figure>  
 
</figure>  
 +
 +
<figure class ="image fit" style = "align:center">
 +
  <img src="https://static.igem.org/mediawiki/2015/7/74/Proof2.png" alt="meso-butanediol consortium">
 +
  <figcaption>Figure 6. - The meso-butanediol standards that back up the above proof!</figcaption>
 +
</figure>
 +
 +
  
 
</div>
 
</div>

Revision as of 03:52, 19 September 2015

iGEM Amsterdam 2015

Testing Romance

Lasting bonds or one-night stand?

Overview

Background

The ultimate test for any romance is lovers living together. Will they cooperate in mutually beneficial ways? Can true microbial romance be sustained? Or will our microbial relationships last no longer than a one night stand? And, in the case of (photo)synthetic consortia designed to benefit mankind by delivering products: can it be used to convert CO2 into a valuable compounds?

Aim

We developed extensive theory about consortia by an interplay of in vivo and in silico approaches shaping each others design. However, all the experimental information we've gathered to help quantitatively understand the consortia was done by cultivating the partners in isolation, trying to mimic the environment they would meet in the co-culture as much as possible. Here, we aim to validate our assumptions and efforts thus far: we want to put the members of our rationally-designed consortium - the carbon-sharing Synechocystis strain and a product-producing E. coli - together in the same compartment to test growth and product formation.

Approach

To assess the development of our consortia and determine final organism ratios, we innoculated 48-well plates with acetate and lactate-producing Synechocystis strains and E. coli. To test product formation, we constructed two consortia: one in which we transformed an E. coli with Bielefeld’s iso-butanol biobrick for the of CO2 to acetate to isobutanol; and another consortium based on an acetoin producing E. coli and Synechocystis engineered to produce glycerol and meso-butanediol from acetoin, showcasing the benefits of compartmentalization in consortia. Both product-producing consortia were tested in batch and turbidostat experiments.

Results

We show growth and organism ratio convergence. And, on the very last day of our project, we finally showed meso-butanodiol production in our consortium! This demonstrates how consortia can be used to implement complex redox production pathways that would be infeasible in a single organism. .

Connections

Acetate Qp and growth
Figure 1. - Romance in action: the organisms are living happily together!/figcaption>
 acetate concentrations
Figure 2. - The eureka moment: our consortium really works!Synechocystis strains.

The first step: showing growth

The first thing we wanted to demonstrate was co-culture growth in which an E. coli culture was able to grow on the carbon shared by Synechocystis. We innoculated 48-well plates with different starting ratios of Synechocystis and E. coli. We used both the lactate-producing Synechocystis strains whose genetic instability we showed earlier, as well as the acetate-producing strain based on the acs knock-out. Cells were counted using a coulter-counter before innoculation and re-counted every 24 hours for seven consecutive days. Results are shown in figure 1 for the acetate producer & E. coli consortium, while results for the lactate-producer & E. coli consortium are shown in figure 2. Overall, all consortia seem to converge to a common final ratio, showing robust population dynamics governed by the carbon-sharing dependency of E. coli on Synechocystis. This result is perfectly aligned with our in silico simulations {link} that had predicted the existence of attractor states, quite robust to fluctuations in model parameters such as the initial ratio of Synechocystis:E. coli.

acetate constructs
Figure 1. - Growth dynamics of acs + e coli consortium.
acetate constructs
Figure 2: Growth dynamics of lactate-producing Synechocystis + e. coli

The next step: demonstrating production

Approach 1: Acetate-production and isobutanol

Our first attempt to demonstate product-production in a synthetic consortium involved our stable acetate-producer and an isobutanol-producing E. coli strain. The latter was obtained via the isobutanol pathway biobrick that was part of this year’s distribution kit and submitted by Bielefeld’s iGEM team last year. Their isobutanol pathway consists of four enzymes under the control of an inducible promoter. Unfortunately, despite succesfully transforming an E. coli strain, we could not demonstrate subsequent isobutanol production in neither stand-alone E. coli growing on various carbon sources nor E. coli driven by Synechocystis stable supply of acetate.

acetate constructs
Approach 3: isobutanol production

Approach 2: Three-step meso-butanodiol production

In an ambitious last attempt to demonstrate product formation using a consortium, we combined an acetoin-producing E. coli strain available in our lab with a previously-engineered Synechocystis strain that produces glycerol via insertions of a gene coding for phospho-glycerol phosphatase (ggp), which catalyzes the dephosphorylation of glycerol-3-phosphate to glycerol (Savakis, 2015). We reasoned that with a modified glycerol-producing strain also created in our lab by Philipp Savakis, the separate compartments of Synechocystis and E. coli could be used to more favourably drive a reaction towards the production of meso-butanediol, an important chemical precursor for a variety of industrial chemicals and biofuels. Previous attempts involved producing meso-butanediol from acetoin within the same compartment in a single cell (figure 2). The flux to meso-butanediol, however, is hampered by the series of redox-reactions with overall unfavourable thermodynamics due to presence in the same compartment. To overcome this, we designed the following consortium:


meso-butanediol consortium
Figure 4. - Consortium design for meso-butanediol production via glycerol and acetoin in a three-step process

After several days of turbidostat innoculation, we managed to show meso-butanediol production using HPLC. Although we obtained these results mere hours before the wiki-freeze and are as such far from being fully exploited, the result demonstrates the potential of using a consortium for successfully driving product-flux using compartmentalisation in what would otherwise be an unfavourable thermodynamic environment.

meso-butanediol consortium
Figure 5. - The peak that shows our consortium works!
meso-butanediol consortium
Figure 6. - The meso-butanediol standards that back up the above proof!